The current shift in the marketing strategy is work by
multinational pharmaceutical Companies. It is now
high-end (rather than adaptive) development that is
being carried out by leading companies. And,
increasingly, other companies are finding themselves
competing against, or working with, new innovation-based
companies. My study focuses on the processes and
outcomes of globally distributed pharmaceutical
companies. This article will present the changing
marketing strategies when a pharma company shift from
Acute base to Chronic therapy base. This research paper
will also give an insight about shift in supply chain
process and customer and end-customer perception which
is the base of formulation of different marketing
strategies. pdf
